Last Update 14 Aug 26
Fair value Increased 43%RPD: Prolonged ARR Weakness And Legacy VM Drag Will Pressure Shares
Rapid7's updated analyst price target has moved sharply higher to around $12 to $15 per share, with analysts pointing to improving margin plans, restructuring efforts, and better-than-expected annual recurring revenue metrics, even as overall growth and legacy vulnerability management trends remain pressured.
Analyst Commentary
Recent research updates on Rapid7 show a wide range of views, even as most analysts lift price targets into the US$9 to US$15 band. The common thread is a focus on execution of the restructuring plan, the health of annual recurring revenue, and the trade off between near term growth pressure and improving profitability.
Bullish Takeaways
- Bullish analysts point to Q2 results that came in ahead of subdued expectations, with several highlighting that Rapid7 delivered key metrics above guidance, which supports the higher price target range around US$12 to US$15.
- Improving margin plans feature heavily in the positive case, with some research citing a path toward about 20% operating margin by Q4 that could support higher valuation multiples if execution stays on track.
- The 12% reduction in force and broader restructuring are seen by supportive analysts as a way to improve profitability and free cash flow, while reallocating spending to the core platform and higher priority products.
- Several neutral to positive views highlight better than feared ARR churn and an updated model that reflects a more efficient cost structure. These analysts see this as creating potential equity upside if Rapid7 can stabilize growth.
Bearish Takeaways
- Bearish analysts emphasize that ARR is still under pressure, with Q2 ARR decelerating and guidance pointing to another decline in Q3 new net ARR. This keeps the growth story in question even after the restructuring.
- Legacy vulnerability management remains a drag on the business, and some research points out that Rapid7 is viewed as behind peers on the pivot toward exposure management, which weighs on growth expectations and stock ratings.
- Several firms that lifted price targets still keep Hold, Underperform or Underweight ratings. They cite concerns that ARR may remain weak for an extended period and that structural changes need time before they are reflected in more durable growth.
- There is also caution around valuation, with comments that shares could be constrained until ARR stabilizes and growth reaccelerates, especially with investors weighing upcoming debt maturity and execution risk on the new strategy.
What’s in the News for Rapid7
- Rapid7 issued revenue guidance for the third quarter of 2026 in a range of US$208 million to US$210 million, and for full year 2026 in a range of US$837 million to US$841 million. (Corporate guidance)
- Rapid7 announced the general availability of Rapid7 Cyber GRC, which adds native governance, risk, and compliance capabilities to the Rapid7 Command Platform and connects GRC workflows with live security operations data. (Product related announcement)
- Since early access launch in May 2026, Rapid7 Cyber GRC has gone through customer validation and commercial adoption and is supported by an assurance partner ecosystem that includes HITRUST, Insight Assurance, and 360 Advanced. (Product related announcement)
- Rapid7 stock has been added to multiple Russell indices, including the Russell Microcap Index, Russell 2000 Value Benchmark, Russell 2500 Value Benchmark, Russell 3000E Index, and related growth and value benchmarks. (Index constituent adds)
- Rapid7 appointed Wael Mohamed as Chief Executive Officer effective June 1, 2026. Former CEO Corey Thomas moved to the role of Executive Chairman, and both continue to serve on the board. (Executive change)
Valuation Changes for Rapid7
- Fair Value has risen from $8.20 to $11.71 per share, representing a sizeable upward reset in the valuation framework used for Rapid7.
- The Discount Rate has fallen from 12.46% to about 11.62%, indicating a slightly lower required return being applied to Rapid7's future cash flows.
- The Revenue Growth assumption has been revised from a decline of about 1.03% to a steeper decline of about 1.52%, reflecting a more conservative view on Rapid7's top line trajectory.
- The Profit Margin expectation has shifted from roughly 4.74% to about 4.69%, which is a very small adjustment and keeps margin assumptions broadly stable for Rapid7.
- The Future P/E has moved from 21.5x to about 32.3x, reflecting a higher valuation multiple being applied to Rapid7's forward earnings assumptions.
Key Takeaways
- Strategic platform offerings and AI-driven automation are positioning Rapid7 for sustained revenue growth and product differentiation in both commercial and federal markets.
- Investments in integrated risk solutions and recurring SaaS revenue, coupled with improving sales execution, provide strong potential for margin expansion and long-term earnings visibility.
- Revenue growth faces uncertainty due to longer deal cycles, persistent legacy declines, operational scaling challenges, intensifying competition, and sustained margin pressures from ongoing investments.
Catalysts
About Rapid7- Provides cybersecurity software and services under the Rapid7, Nexpose, and Metasploit brand names.
- Rapid7's unified Command platform and MDR-led solutions are increasingly winning larger, strategic consolidation deals as enterprises seek to reduce fragmentation and simplify compliance in complex, highly regulated environments-pointing to an expanding addressable market, higher average revenue per customer, and sustained revenue growth opportunity.
- Growing enterprise demand for AI-integrated, automated security operations is playing to Rapid7's strengths, with Agentic AI and proprietary SOC expertise embedded in offerings like Incident Command-supporting product leadership and the potential for future topline and margin expansion as efficiency and differentiation improve.
- Strategic investments in exposure management and integration of on-premise and cloud risk solutions are resulting in larger upgrade deals and higher ASPs than initially forecast, though with longer sales cycles; this indicates an underappreciated upsell/cross-sell runway that could drive significant ARR and margin gains once go-to-market execution matures.
- A shift toward recurring SaaS subscription revenue, strong international growth (10% YoY) and prudent operating discipline (high gross margins and robust free cash flow) are creating improved visibility on future earnings and potential for net margin expansion as volume and operational scale increase.
- Recent FedRAMP authorization opens a substantial new federal market segment for Rapid7, with government demand for end-to-end cybersecurity suites acting as a multi-year growth catalyst likely to impact revenue and ARR starting in fiscal 2026 and beyond.
Rapid7 Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Rapid7's revenue will decrease by 1.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 2.4% today to 4.7% in 3 years time.
- Analysts expect earnings to reach $38.3 million (and earnings per share of $0.54) by about August 2029, up from $20.1 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 32.3x on those 2029 earnings, down from 46.1x today. This future PE is lower than the current PE for the US Software industry at 32.8x.
- Analysts expect the number of shares outstanding to grow by 4.1% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 11.62%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Extended deal cycles and a shift towards larger, more strategic deals are increasing revenue timing uncertainty and reducing predictability, which could result in slower or more volatile near-term and long-term revenue growth.
- Persistent declines or stagnation in legacy vulnerability management (VM) and smaller-dollar transactional customers, without sufficient growth in new high-value customers, may weigh on overall ARR and hinder future revenue and earnings expansion.
- Difficulty operationalizing and scaling the expansion/upsell engine, as highlighted by management's own admission that continuous expansion engine and easier bite-size adoption for customers are lacking, could limit the growth of average revenue per customer (ARPU) and restrict margin/profit improvement.
- Intensifying competition from hyperscalers with integrated security platforms, and industry consolidation favoring larger, more comprehensive vendors, poses long-term risks to Rapid7's market share, pricing power, and ultimately revenue and margins.
- Elevated investment in R&D, expanded SOC operations (notably in India), and sales go-to-market transformation initiatives could sustain or worsen margin pressures, especially if revenue growth does not accelerate as anticipated, negatively impacting operating income and free cash flow.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $11.71 for Rapid7 based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $15.0, and the most bearish reporting a price target of just $8.76.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $817.5 million, earnings will come to $38.3 million, and it would be trading on a PE ratio of 32.3x, assuming you use a discount rate of 11.6%.
- Given the current share price of $13.78, the analyst price target of $11.71 is 17.7% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Rapid7?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.